Early use of erenumab in US real-world practice

• Päätekijät: Alina Bogdanov (Tekijä), Victoria Chia (Tekijä), Mark Bensink (Tekijä), Robert Urman (Tekijä), Lauren Fischer (Tekijä), Soeren Rasmussen (Tekijä), Christine Szekely (Tekijä), Lee Kallenbach (Tekijä)
• Aineistotyyppi: Kirja
• Julkaistu: SAGE Publishing, 2021-05-01T00:00:00Z.
• Aiheet: article
• Linkit: Connect to this object online.

Background: Erenumab, a monoclonal antibody (mAb) developed to block the calcitonin gene-related peptide (CGRP) receptor, is approved for the prevention of migraine in adults. This retrospective observational study sought to describe early real-world use of erenumab. Methods: This study used the Pra...